Alcohol usage, football and young fans

Drug usage is a bio-psychosocial phenomenon, composed by the triad substance, individual and social context. Aiming to evaluate the patterns of consumption among young football fans, the study was conducted from a sociological approach combined with bibliographical, document and field research using AUDIT. The intentional sample comprised 263 male subjects, ages between 15 and 25, residents of Sao Paulo city. The subjects were approached randomly, which was done on days with football matches from the Sao Paulo State League (Campeonato Paulista de Futebol). The data indicated a high pattern of beverage consumption. The theme's complexity demands a multifarious look, taking into consideration the fact that the drug is an inanimate product that depends on the user to manifest its effects and consequences, i.e., it is rather the use one makes of leisure and drinking that may represent problems, and not leisure and drinking per se.15354155

Cup law, alcohol and the conception process of a legislation to violence

This paper deals with the General Law of the World Cup which is being processed in Congress since September 2011, under the symbol PL 2330/2011 written by the executive branch. In such an analysis is made on the General Law of the World Cup and the construction of the legislation on prevention of violence and in sporting events, more detail on the controversial link between alcohol and violence.181699

Women's Futsal in South America: trajectories of confrontations and conquests

19321123

Assessment of bleeding events in patients receiving DOACs with or without statins to treat venous thromboembolism: insights from the RIETE registry

Objective To evaluate the impact of coadministering statins with direct oral anticoagulants (DOACs) on the risk of major bleeding events in patients with venous thromboembolism (VTE).Design Observational cohort analysis based on a multicentre international registry.Setting Data were extracted from the Registro Informatizado de Enfermedad TromboEmbolica Registry, which involves 205 centres across 27 countries.Participants A total of 73 659 patients diagnosed with VTE were classified based on their anticoagulant therapy (DOACs) versus low-molecular-weight heparin (LMWH) or vitamin K antagonists (VKAs) and concurrent use of statins.Methods Multivariable Cox proportional hazards models adjusted for confounding variables to assess the risk of major bleeding events stratified by the type of anticoagulant use and statin use.Results From October 2013 to February 2023, 73 659 patients were recruited: 2573 were statin users on DOACs, 14 090 were statin users on LMWH or VKA therapy, 10 088 were non-statin users on DOACs and 46 908 were non-statin users on LMWH or VKA therapy. Statin users were 10 years older and more likely to have hypertension, diabetes, renal failure or prior artery disease. During anticoagulation (median, 187 days), 1917 patients (2.6%) suffered major bleeding. Rates of major bleeding per 100 patient-years were 2.33 (95% CI 1.72 to 3.09), 3.75 (95% CI 3.43 to 4.10), 1.39 (95% CI 1.13 to 1.69) and 3.10 (95% CI 2.93 to 3.27), respectively. On multivariable analysis, patients treated with DOACs had a significantly lower risk of major bleeding compared with those on LMWH or VKA therapy (adjusted HR 0.59; 95% CI 0.48 to 0.74). The adjusted HR in statin users versus non-users was 1.03 (95% CI 0.92 to 1.14), while in statin users on DOACs versus the rest of patients, it was 1.18 (95% CI 0.79 to 1.76).Conclusions In patients with VTE receiving statins, long-term anticoagulation with DOACs was associated with a reduced risk of major bleeding, regardless of the statin use. These findings support the safety profile of DOACs over VKAs or LMWH in the management of VTE in patients requiring statins